The mainstay of therapy for gonococcal infections is antimicrobial therapy.<unk>  treatment is complicated by the ability of N.<unk> e to develop<unk>  to antimicrobials, therefore a combination therapy with Azithromycin and a Cephalosporin is used to improve treatment efficacy and potentially slow the emergence and spread of<unk> .
Gonorrhea Drug resistance
Gonorrhea risk factors
Brucellosis risk factors
Salmonellosis risk factors
Neurosyphilis risk factors
Schistosomiasis risk factors
Malaria risk factors
Tularemia risk factors